Skip to content
★ Sign in to follow
NW

Nicholas Waters

IRLAB Therapeutics AB
Total declarations
4
Company
1
▲ Purchases (1 ops.)
€16k
▼ Sales (0 ops.)
—

Latest filing published 29 Jun 2026 for IRLAB Therapeutics AB, €27k.

Filing timeline

BuySale
Nicholas Waters

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Nicholas Waters: trading record in brief

Nicholas Waters is a declared insider of IRLAB Therapeutics AB, with filings sourced from Finansinspektionen. In total, 4 filings cover trades dated from 10 July 2019 to 26 June 2026.

The open-market record is one-sided, with 1 purchase worth €16k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The record was last updated on 29 June 2026 with a transaction (€27k) in IRLAB Therapeutics AB. The most recent open-market purchase was published on 27 February 2020, 2,445 days ago. Filings reach the Finansinspektionen feed a median of 1 day after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Nicholas Waters

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesIRLAB Therapeutics AB
    300,000 SEK0FI-SE
    250,000 shares@ SEK 1.20100.0% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-644fe006c9298328bad7
  • ▲
    VDExecutivesIRLAB Therapeutics AB
    169,992 SEK0FI-SE
    6,296 shares@ SEK 27.0037.4% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-a6fcd8b8600df2c16a92
    Canonical exit: 25 May 2020 (T+90)
  • ●
    VDExecutivesIRLAB Therapeutics AB
    3M SEK0FI-SE
    31,299 shares@ SEK 92.18AktieISIN SE0012675379FI:csv-d143dfb1eab26eb9d5e0

3 of 3 declarations